AP2α was indeed found to interact with the predicted sites on the GAS2 and on KLK-5 upstream regulatory sequences in the cancer cells as well as to the AP2α binding site in the promoter of the estrogene receptor gene used as a positive control (ESR1, Figure 5B). The gene discussed is ESR1; the disease is cancer.